免疫适应不良相关早发型子痫前期与代谢综合征相关晚发型子痫前期病理生理学理解进展
本文综述了子痫前期的两种亚型:早发型与免疫适应不良相关,晚发型(>34周)与母体代谢综合征相关。父源性抗原特异性调节性T细胞在维持妊娠中起重要作用,其在子痫前期中减少。低剂量阿司匹林(<16周开始)可预防最多60%的早发型子痫前期,但不预防晚发型。优化孕前体重和控制孕期增重可能是最有效的预防方法。
要点
- 早发型子痫前期与免疫适应不良相关,晚发型(>34周)与代谢综合征相关。
- 父源性抗原特异性调节性T细胞减少和细胞毒性T细胞PD-1表达降低参与早发型子痫前期的发生。
- 低剂量阿司匹林(<16周开始)可预防最多60%的早发型子痫前期,但不预防晚发型。
核心结论
- 早发型子痫前期与免疫适应不良相关,晚发型子痫前期与代谢综合征相关;合体滋养细胞应激是各亚型导致母体综合征的共同最终通路。
研究设计与样本
- 综述,未报告检索范围。
主要发现
- 在子痫前期病例的底蜕膜中,克隆性调节性T细胞减少。
- 子痫前期中克隆性细胞毒性T细胞上PD-1表达降低,早发型子痫前期尤为明显。
- 晚发型子痫前期(>34周)在多数发达国家占子痫前期的80%至90%,与母体心血管代谢变量(代谢综合征)强相关。
- 合体滋养细胞应激通过引起促血管生成因子(胎盘生长因子和血管内皮生长因子)与抗血管生成因子(可溶性fms样酪氨酸激酶-1和可溶性内皮糖蛋白)失衡,成为各亚型子痫前期导致母体综合征的共同最终通路。
关键数值与推荐
- 低剂量阿司匹林在妊娠16周前开始,可预防最多60%的早发型子痫前期,但不能预防晚发型子痫前期。
- 优化孕前体重和控制孕期增重可能是预防子痫前期最有效的方法。
临床怎么用
- 低剂量阿司匹林在妊娠16周前开始可用于预防早发型子痫前期。
- 优化孕前体重和控制孕期增重可能有助于预防子痫前期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Among mammalian species, human reproduction has 2 outstanding features. The human hemochorial placentation is characterized by a very deep endovascular trophoblast invasion in the spiral arteries, reaching deep into the myometrium. This requires an agonistic direct cell-cell interaction between the maternal immune system and semiallogeneic trophoblast. The second feature is preeclampsia, a heterogeneous syndrome, a uniquely human condition. The human female is one of the few mammals exposed to her partner's semen on multiple occasions before conception. Regulatory T cells, especially paternal antigen-specific regulatory T cells, play an important role in the maintenance of pregnancy. Sexual intercourse increases the number of dendritic cells in the uterus that play an important role in the induction of paternal antigen-specific regulatory T cells. Paternal antigen-specific regulatory T cells maintain pregnancy by inducing tolerance. In the decidua basalis of preeclamptic cases, clonal regulatory T cells are reduced; these would normally monoclonally expand to recognize fetal or paternal antigens. Programmed cell death-1 expressed on T cells regulate cytotoxic T-cell activity and protect the fetus against maternal rejection. Programmed cell death-1 expression on clonal cytotoxic T cells is reduced in preeclampsia especially in early-onset preeclampsia, making the fetus and placenta vulnerable to attack by cytotoxic T cells. These phenomena can explain the epidemiologic phenomenon that preeclampsia is more common in couples using condom contraception, with shorter cohabitation periods, first pregnancies, first pregnancies in multiparous women when they change partner, and pregnancies after assisted reproduction using donated gametes. In contrast to its importance in early-onset preeclampsia, shallow trophoblast invasion does not play a role in the development of preeclampsia, that is, immune maladaptation does not seem to be involved. Late-onset preeclampsia (>34 weeks' gestation), representing 80% to 90% of preeclampsia in most developed countries with a "Western lifestyle," is strongly associated with maternal cardiometabolic variables (metabolic syndrome). Although the underlying pathophysiology might be quite different, syncytiotrophoblast stress is the final common pathway leading to the maternal syndrome among the subtypes of preeclampsia by causing an imbalance between proangiogenic factors (placental growth factor and vascular endothelial growth factor) and antiangiogenic factors (soluble fms-like tyrosine kinase-1 and soluble endoglin). Low-dose aspirin, started before 16 week's gestation, will prevent up to 60% of early-onset preeclampsia but will not prevent late-onset preeclampsia. Optimizing prepregnancy weight and controlling gestational weight gain may be the most effective ways to prevent preeclampsia.
引用
- Robillard PY, Dekker G, Scioscia M, et al. Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia. Am J Obstet Gynecol. 2022. PMID: 35177223. doi:10.1016/j.ajog.2021.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。